2. Gene
  3. CDK1 - cyclin dependent kinase 1 Gene

CDK1 - cyclin dependent kinase 1 Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

中文名称：细胞周期蛋白依赖性激酶 1

种属: Sus scrofa

同用名: CDC2

基因 ID: 100155762 | 基因类型: protein coding

关于 CDK1

Primary_assembly 14: 64,233,987-64,372,197 forward strand.Sscrofa11.1:CM000825.5

This gene has 6 transcripts (splice variants), 246 orthologues and 27 paralogues. Broad expression in ovary (RPKM 4.3), spleen (RPKM 2.8) and 8 other tissues.

CDK1 基因产物(1)

mRNA Protein Name
NM_001159304.2 NP_001152776.1 cyclin-dependent kinase 1

CDK1 蛋白结构

STKc_CDK1_euk

STKc_CDK1_euk: cd07861 (2 - 286)

  • 0
  • 100
  • 200
  • 297 a.a.
蛋白主名 其他名称

cyclin-dependent kinase 1

cell division cycle 2, G1 to S and G2 to M

相关产品

Approval
生物活性分子 (3)
目录号 产品名 作用方式
纯度 是否罕见病
HY-16297A Abemaciclib Inhibitor 99.96% 是
HY-10492 Dinaciclib Inhibitor 99.44% 是
HY-16297 Abemaciclib methanesulfonate Inhibitor 99.95% 是
Clinical Phase
生物活性分子 (25)
目录号 产品名 作用方式
纯度 Phase
HY-10580 GSK 3 Inhibitor IX Inhibitor 99.74% Phase 4
HY-10005 Flavopiridol Inhibitor 99.72% Phase 2
HY-30237 (R)-Roscovitine Inhibitor 98.73% Phase 2
HY-50940 AT7519 Inhibitor 99.76% Phase 2
HY-10006 Flavopiridol Hydrochloride Inhibitor 98.95% Phase 2
HY-103712A Samuraciclib hydrochloride Inhibitor 99.98% Phase 2
HY-13914 Roniciclib Inhibitor 98.03% Phase 2
HY-10424 Milciclib Inhibitor 99.89% Phase 2
HY-103712B Samuraciclib hydrochloride hydrate Inhibitor 99.08% Phase 2
HY-16559 Riviciclib hydrochloride 99.01% Phase 2
HY-50943 AT7519 Hydrochloride Inhibitor 99.42% Phase 2
HY-112272A Lerociclib dihydrochloride Inhibitor 99.74% Phase 2
HY-137432A Avotaciclib trihydrochloride Inhibitor ≥95.0% Phase 2
HY-112272 Lerociclib Inhibitor / Phase 2
HY-137432 Avotaciclib Inhibitor / Phase 2
HY-16559A Riviciclib Inhibitor / Phase 2
HY-10008 SNS-032 Inhibitor 99.49% Phase 1
HY-10012 AZD-5438 Inhibitor 99.85% Phase 1
HY-12871B Atuveciclib Inhibitor 99.80% Phase 1
HY-11001 PHA-793887 Inhibitor 99.25% Phase 1
HY-15504 RGB-286638 Inhibitor 99.84% Phase 1
HY-12422 Voruciclib Inhibitor 99.73% Phase 1
HY-15504A RGB-286638 free base Inhibitor 98.07% Phase 1
HY-12422A Voruciclib hydrochloride Inhibitor 99.23% Phase 1
HY-50940A AT7519 TFA Inhibitor 98.53% Phase 1
Pre-clinical Phase
生物活性分子 (73)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-12529 Ro-3306 Inhibitor 99.04% 否
HY-12302 Kenpaullone Inhibitor 98.16% 否
HY-10329 JNJ-7706621 Inhibitor 99.91% 否
HY-15154 NG 52 Inhibitor 99.97% 否
HY-11009 CGP60474 Inhibitor 99.23% 否
HY-124719 hSMG-1 inhibitor 11j Inhibitor 99.81% 否
HY-15339 CVT-313 Inhibitor 99.76% 否
HY-10014 R547 Inhibitor 99.57% 否
HY-15275 BMS-265246 Inhibitor 98.92% 否
HY-N0417 Cucurbitacin E Inhibitor 99.92% 否
HY-13266A BS-181 hydrochloride Inhibitor 99.80% 否
HY-18299A Purvalanol A Inhibitor 98.30% 否
HY-13461A PHA-767491 hydrochloride Inhibitor 98.06% 否
HY-15569 NU6102 Inhibitor 99.68% 否
HY-18340A (R)-CR8 trihydrochloride Inhibitor 98.95% 否
HY-18299 Purvalanol B Inhibitor ≥97.0% 否
HY-12445 Asnuciclib Inhibitor 99.76% 否
HY-18629 SU9516 Inhibitor 99.81% 否
HY-117535 CDK2-IN-4 Inhibitor 98.07% 否
HY-15878 LDC000067 Inhibitor 98.00% 否
HY-124760 hSMG-1 inhibitor 11e Inhibitor 99.18% 否
HY-18340 (R)​-​CR8 Inhibitor 99.21% 否
HY-X0150 JSH-150 Inhibitor 98.36% 否
HY-103647 K00546 Inhibitor 98.08% 否
HY-12280 THZ2 Inhibitor 99.03% 否
HY-119940 MC180295 Inhibitor 98.41% 否
HY-15889 AMG 925 Inhibitor 98.24% 否
HY-107419 NU6140 Inhibitor 99.51% 否
HY-15241 NVP-LCQ195 Inhibitor 98.91% 否
HY-103712C Samuraciclib hydrochloride hydrate Inhibitor 99.88% 否
HY-108359 Alsterpaullone Inhibitor 98.38% 否
HY-129478 TC11 Activator 98.04% 否
HY-148062 RSS0680 98.03% 否
HY-103221 MeBIO Inhibitor ≥98.0% 否
HY-100429 CAN508 Inhibitor 99.59% 否
HY-153556 GW297361 Inhibitor 98.13% 否
HY-19316 NU2058 Inhibitor 98.78% 否
HY-N5072 Desmethylglycitein Inhibitor 98.98% 否
HY-112463 CDK1-IN-2 Inhibitor 97.17% 否
HY-15889A AMG 925 HCl Inhibitor / 否
HY-111930 5-Iodo-indirubin-3'-monoxime Inhibitor 99.50% 否
HY-13816 NU6027 Inhibitor 99.35% 否
HY-139980 CDK9-IN-13 Inhibitor 99.22% 否
HY-13266 BS-181 Inhibitor 98.10% 否
HY-14372 BS-194 Inhibitor / 否
HY-111237 Butyrolactone I Inhibitor 98.03% 否
HY-114903 (E/Z)-BIO-acetoxime Inhibitor / 否
HY-13461 PHA-767491 Inhibitor / 否
HY-151409 CDK1-IN-5 Inhibitor / 否
HY-151407 CDK1-IN-3 Inhibitor / 否
HY-126244 CDK4/6-IN-3 Inhibitor / 否
HY-103712 Samuraciclib Inhibitor / 否
HY-112462 Cdk1/2 Inhibitor III Inhibitor / 否
HY-112336 Aloisine RP106 Inhibitor / 否
HY-115924 CDK1-IN-1 Inhibitor / 否
HY-155787 SHR5428 Inhibitor / 否
HY-142696 CDK6/PIM1-IN-1 Inhibitor / 否
HY-146253 CDK1/2/4-IN-1 Inhibitor / 否
HY-151408 CDK1-IN-4 Inhibitor / 否
HY-147901 KDM1/CDK1-IN-1 Inhibitor / 否
HY-151878 CDK7-IN-20 Inhibitor / 否
HY-146276 CDK/HDAC-IN-2 Inhibitor / 否
HY-141685 3-Methylthienyl-carbonyl-JNJ-7706621 Inhibitor / 否
HY-112363 Aloisine A Inhibitor / 否
HY-147646 CDK1/Cyc B-IN-1 Inhibitor / 否
HY-136726 CGP-82996 Inhibitor / 否
HY-112346 RGB-286147 Inhibitor / 否
HY-115942 Anticancer agent 29 Inhibitor / 否
HY-103381 NSC693868 Inhibitor / 否
HY-151898 CDK4/6-IN-14 Inhibitor / 否
HY-103383 (R)-DRF053 dihydrochloride Inhibitor / 否
HY-111931 Indirubin-3'-monoxime-5-sulphonic acid Inhibitor / 否
HY-111932 Indirubin-5-sulfonate Inhibitor / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens CDK1 NCBI NCBI:983
Mus musculus CDK1 NCBI NCBI:12534